FHTX vs FULC

Foghorn Therapeutics Inc. vs Fulcrum Therapeutics, Inc. — Valuation Comparison 2026

FHTX

Biotechnology
Foghorn Therapeutics Inc.
Quality
6.3
out of 10
Value Trap
24
SAFE
Price
$4.27
Last close
Models
7/13
Active
VS

FULC

Biotechnology
Fulcrum Therapeutics, Inc.
Quality
6.5
out of 10
Value Trap
18
SAFE
Price
$6.82
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType FHTX Fair ValueFHTX Upside FULC Fair ValueFULC Upside
Bayesian DCF Intrinsic $1.34 -68.5% $2.23 -67.3%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.53 -87.6% $0.36 -94.5%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $8.29 +94.0% $6.52 -4.4%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for FHTX vs FULC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

FHTX vs FULC — Which Stock Is More Undervalued?

FULC scores higher with a 6.5/10 quality rating vs FHTX's 6.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Foghorn Therapeutics Inc. (FHTX) and Fulcrum Therapeutics, Inc. (FULC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

FHTX currently trades at $4.27 with a QOC of 6.3/10, while FULC trades at $6.82 with a QOC of 6.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).